Clinical trial starts for novel heart failure drugs U.S. 2009-2018, by stage

Published by
Matej Mikulic,
Dec 12, 2022
In 2018, eight phase II clinical trials for novel heart failure drugs were started in the United States, compared to four and one clinical trials started in phase I and phase III, respectively. This statistic illustrates the number of clinical trial starts for novel heart failure drugs in the United States from 2009 to 2018, by stage.

Number of clinical trials starts for novel heart failure drugs in the U.S. from 2009 to 2018, by phase

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2020

Region

United States

Survey time period

2009 to 2018

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Global overview

4

Top companies' top products

5

Best-selling drugs

8

U.S. overview

4

Outlook

5

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu